Kestra Medical Secures $467M to Revolutionize Cardiac Care with Wearable Innovations

Kestra Medical Technologies, Inc. is thrilled to announce a significant milestone in our mission to revolutionize cardiac care with the successful raise of $467,000,000 in new funding. This landmark investment further fuels our commitment to supporting patients at-risk for cardiovascular disease—the world’s leading cause of death—and the healthcare professionals dedicated to their care. As a privately held company and part of the Bain Capital portfolio, we remain steadfast in our vision: to provide innovative wearable technologies, intuitive tools, and comprehensive solutions that streamline cardiac monitoring and facilitate definitive therapy. Our advanced wearable products and applications are designed to offer unprecedented ease and comfort during recovery, ensuring that patients not only receive cutting-edge clinical insights but also benefit from the reassurance of continuous, personalized care. The fresh infusion of capital is intended to accelerate our product development, expand our technological capabilities, and extend our market reach. With this funding, we are poised to invest in research and development that propels our breakthrough solutions from concept to clinical application, ultimately translating into improved outcomes for patients navigating life’s most challenging medical events. Headquartered in Kirkland, Washington, Kestra Medical Technologies is proud to stand at the forefront of innovation in the medical technology landscape, combining patient-centric care with scalable technology. We invite all stakeholders, partners, and the broader community to join us in this exciting phase of growth as we continue to empower healthcare teams worldwide with the tools and insights necessary to transform cardiac care. Visit us at www.kestramedical.com to learn more about our journey and our vision for the future.